Status: Recruiting
Investigating the Effects of Cannabidiol on Social Anxiety Disorder
The purpose of this study is to test whether a single-dose of Epidiolex (cannabidiol) is associated with reduced psychological, physiological, and neuroimaging measures of anxiety in people diagnosed with social anxiety disorder (SAD).
Participants needed: 50
Trial details
Phase: Phase 4Age: 18-55Biological sex: AllType: InterventionalSponsor: Massachusetts Institute of TechnologyUpdated: Dec 3, 2025Locations: 1
Eligibility criteria
Ability and willingness to provide written informed consent. [+7]
History of bipolar disorder, schizophrenia, psychosis, delusional disorders. [+17]